Drugs |
Dosage |
Specific indications |
Contraindications |
Sacubitril/valsartan |
24/26-97/103 mg bid |
Congestive heart failure |
As in ARBs (see table 3.9-3) |
Doxazosin |
1-16 mg once daily |
Prostatic hypertrophy |
Orthostatic hypotension, heart failure |
Terazosin |
1-20 mg once daily | ||
Methyldopa |
0.25-1 g bid |
Hypertension in pregnancy; use in combination with a diuretic |
Liver failure, pheochromocytoma, hemolytic anemia, depression, sexual dysfunction |
Clonidine |
0.05-0.2 mg bid to tid |
Use in combination with a diuretic |
Renal or liver failure, depression, sick sinus syndrome, bradyarrhythmia |
Moxonidinea |
0.2-0.6 mg/d |
Mild and moderate hypertension, especially in young patients with symptoms of sympathetic activation |
Severe depression, severe renal failure |
Rilmenidinea |
1 mg once daily to bid | ||
Hydralazine |
75-200 mg/d in 3-4 divided doses |
Use in exceptional cases in combination with a diuretic and a beta-blocker |
Tachycardia, cerebrovascular disease, mitral stenosis, aortic aneurysm, hypertrophic cardiomyopathy, ischemic heart disease, liver and kidney dysfunction, porphyria |
a Not available in Canada. | |||
ARB, angiotensin receptor blocker; bid, 2 times a day; tid, 3 times a day. |